Literature DB >> 15811870

American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care.

John A Spertus, Kim A Eagle, Harlan M Krumholz, Kristi R Mitchell, Sharon-Lise T Normand.   

Abstract

The ability to quantify the quality of cardiovascular care critically depends on the translation of recommendations for high-quality care into the measurement of that care. As payers and regulatory agencies increasingly seek to quantify healthcare quality, the implications of the measurement process on practicing physicians are likely to grow. This statement describes the methodology by which the American College of Cardiology and the American Heart Association approach creating performance measures and devising techniques for quantifying those aspects of care that directly reflect the quality of cardiovascular care. Methods for defining target populations, identifying dimensions of care, synthesizing the literature, and operationalizing the process of selecting measures are proposed. It is hoped that new sets of measures will be created through the implementation of this approach, and consequently, through the use of such measurement sets in the context of quality improvement efforts, the quality of cardiovascular care will improve.

Mesh:

Year:  2005        PMID: 15811870     DOI: 10.1161/01.CIR.0000157096.95223.D7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Eric D Peterson; P Michael Ho; Mary Barton; Craig Beam; L Hayley Burgess; Donald E Casey; Joseph P Drozda; Gregg C Fonarow; David Goff; Kathleen L Grady; Dana E King; Marjorie L King; Frederick A Masoudi; David R Nielsen; Stephen Stanko
Journal:  Circulation       Date:  2014-11-03       Impact factor: 29.690

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Evaluation of quality in adult cardiac surgery: let us speak the same language.

Authors:  L Noyez; P C Kievit; M W A Verkroost; H B van Wetten; A F T M Verhagen; H A van Swieten
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

4.  Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach.

Authors:  Karen Tu; Lindsay Bevan; Katie Hunter; Jess Rogers; Jacqueline Young; Gihad Nesrallah
Journal:  CMAJ Open       Date:  2017-01-25

5.  Statistical methodology for classifying units on the basis of multiple-related measures.

Authors:  Armando Teixeira-Pinto; Sharon-Lise T Normand
Journal:  Stat Med       Date:  2008-04-30       Impact factor: 2.373

6.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

7.  Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.

Authors:  Merrill Thomas; Yevgeniy Khariton; Gregg C Fonarow; Suzanne V Arnold; Larry Hill; Michael E Nassif; Puza P Sharma; Javed Butler; Laine Thomas; Carol I Duffy; Adam D DeVore; Adrian Hernandez; Nancy M Albert; J Herbert Patterson; Fredonia B Williams; Kevin McCague; John A Spertus
Journal:  JACC Heart Fail       Date:  2019-06-05       Impact factor: 12.035

8.  Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Authors:  Sharon Cresci; Philip G Jones; Carmen C Sucharov; Sharon Marsh; David E Lanfear; Adam Garsa; Michael Courtois; Carla J Weinheimer; Jun Wu; Michael A Province; Daniel P Kelly; Howard L McLeod; John A Spertus
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

9.  Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon
Journal:  Circ Heart Fail       Date:  2013-04-24       Impact factor: 8.790

10.  Canadian quality indicators for percutaneous coronary interventions.

Authors:  Dennis T Ko; Harindra C Wijeysundera; Xiaofu Zhu; Janice Richards; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.